DAVID B WILHELM
Allopathic & Osteopathic Physicians|Internal Medicine BIRMINGHAM, AL NPI 1134155195
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine AL ABBVIE INC. All categories
General Payments — all program years on this page
$14,765.68
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,003
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,897.04 across 119 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,897.04 | 119 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $448.40 | 42 |
| Bayer HealthCare Pharmaceuticals Inc. | $302.57 | 11 |
| Novo Nordisk AS | $225.94 | 13 |
| Lilly USA, LLC | $165.83 | 11 |
| Amgen Inc. | $139.94 | 9 |
| PFIZER INC. | $109.90 | 6 |
| Antares Pharma, Inc. | $99.10 | 5 |
| Acerta Pharma LLC | $51.98 | 3 |
| DEXCOM, INC. | $46.37 | 2 |
| SHIELD THERAPEUTICS INC | $41.32 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $36.85 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $34.17 | 2 |
| Teva Pharmaceuticals USA, Inc. | $34.06 | 2 |
| TOLMAR, INC. | $27.22 | 2 |
| Biosense Webster, Inc. | $26.52 | 1 |
| Abbott Laboratories | $24.76 | 1 |
| GlaxoSmithKline, LLC. | $19.00 | 1 |
| ITI, Inc. | $17.65 | 1 |
| Astellas Pharma US Inc | $17.28 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.21 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.97 | 1 |
By program year
Records — PY2024 (119)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.